cd66a863a0
- Source: inbox/queue/2026-05-05-npr-glp1-eating-disorders-not-well-understood.md - Domain: health - Claims: 2, Entities: 0 - Enrichments: 4 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
2.3 KiB
| type | domain | description | confidence | source | created | title | agent | sourced_from | scope | sourcer | supports | related | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| claim | health | Atypical anorexics meet full diagnostic criteria for anorexia nervosa despite normal or elevated BMI, making them appear as ideal GLP-1 candidates to prescribers using weight-based screening alone | experimental | Dr. Kim Dennis (eating disorder specialist), NPR investigation | 2026-05-05 | GLP-1 prescribing creates systematic risk for atypical anorexia patients because BMI-based eligibility screening cannot detect restrictive psychopathology in overweight individuals | vida | health/2026-05-05-npr-glp1-eating-disorders-not-well-understood.md | structural | NPR (@NPRHealth) |
|
|
GLP-1 prescribing creates systematic risk for atypical anorexia patients because BMI-based eligibility screening cannot detect restrictive psychopathology in overweight individuals
Dr. Kim Dennis identifies a structural screening gap: patients with atypical anorexia nervosa meet full diagnostic criteria for restrictive eating disorders despite having normal or elevated BMI. To a prescriber using standard weight-based eligibility criteria, these patients appear as ideal GLP-1 candidates—overweight individuals seeking medically supervised weight loss. However, they have active restrictive psychopathology that GLP-1s would amplify. The NPR piece quotes Dennis specifically raising concern for 'atypical anorexics' who 'appear like ideal GLP-1 candidates to an unaware prescriber.' This creates a population-specific harm pathway that standard BMI screening cannot detect. The mechanism is invisibility: the very criterion that makes someone eligible (elevated BMI) masks the psychological contraindication (active restriction). This is distinct from general eating disorder risk—it's a specific population where the eligibility criterion and the risk factor are structurally confounded.